You are here

Mydecine Innovations Group Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
MYCO
CSE Index: 
Currency: 

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

You are here

Mydecine Innovations Group Inc. (MYCO)

SEDAR Information

Company Info

Address
789 W Pender Street, Suite 810
Vancouver, BC V6C 1H2
Canada
Phone
604-687-2038
Email
contact@mydecineinc.com
Website
http://www.mydecineinc.com
Listing date
Monday, August 18, 2014
Transfer Agent
National Securities Administrators Ltd.
Investor Relations
D. Joshua Bartch
Email
contact@mydecineinc.com
Auditor
Adam Sung Kim Ltd.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
227,275,407
Reserved for Issuance: 
52,748,136

Bulletins

12/02/2021

2021-0228 – New Listing - Mydecine Innovations Group Inc. Warrants (MYCO.WT)

Le 12 février/February 2021

Mydecine Innovations Group Inc. Warrants (the "Warrants") have been approved for listing.

Each Warrant shall, entitle the holder thereof to acquire one (1) Common Share after the Issue Date and prior to the Expiry Time,  upon payment of the Exercise Price of $0.70.

See the Warrant Indenture for full details.

_____________________

Les bons de souscription de Mydecine Innovations Group Inc. (les «bons de souscription») ont été approuvés pour inscription.

Advertisement

Publicité

Latest CSE News

Upcoming Events

PDAC_website.png

Virtual PDAC 2021

Monday, March 8, 2021 to Thursday, March 11, 2021
PDAC_Invite_2021_CSE_Website_740x374_1.jpg

Ridi, Bevi, e Divertiti

Tuesday, March 9, 2021 -
3:00pm to 5:00pm